Virios Therapeutics, Inc. (NASDAQ:VIRI) Q1 2024 Earnings Call Transcript May 11, 2024
Virios Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good morning, and welcome to the Virios Therapeutics Incorporated First Quarter 2024 Earnings Call. At this time, all participants have been placed on a listen-only mode. Please be advised that today’s call is being recorded at the company’s request. At this...
